Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blackstone
Biotech
Merck bags $700M from Blackstone, spends $150M to regain asset
Merck is paying $150 million upfront for full control of an early-phase asset and pocketing $700 million to fund an expansive pivotal oncology push.
Nick Paul Taylor
Nov 4, 2025 9:15am
Hologic to go private with $18.3B deal by Blackstone and TPG
Oct 22, 2025 8:45am
Blackstone buys majority stake in CMIC, Japan's largest CRO
Mar 4, 2025 2:37pm
Novartis inks $925M Anthos takeover to rejoin clot-busting race
Feb 11, 2025 5:21am
Blackstone unsheathes Uniquity Bio with $300M
May 15, 2024 11:00am
Blackstone bets $750M on Moderna's flu program
Mar 27, 2024 8:54am
